Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Top Headlines

WuXi Biologics' facility in Dundalk, Ireland

WuXi Biologics: Ireland’s largest single-use facility underway

The CDMO has broken ground on its first site outside of China – a €325m single-use manufacturing facility in County Louth, Ireland.

Europe approves Mundipharma’s Neulasta biosimilar

The European Commission approved a pegfilgrastim biosimilar from Mundipharma after the network acquired Cinfa Biotech.

UK-funded study to investigate patients’ experience of cell and gene therapies

Innovate UK is helping to fund the PROmics study, a programme designed to assess the effect of cell therapies on patient symptoms and quality of life.

Leukemia licensing deal could potentially cost Janssen more than $1.8bn

Janssen has entered a global licensing agreement with argenx to develop and commercialize a treatment for acute myeloid leukemia.

Start-up develops cell replacement therapy to ‘make hair loss history’

Scientists, hair transplant surgeons and patients have collaborated to develop personalised cell replacement therapies for baldness.

Global Industry News

Hot Topics

Spotlight

Samsung BioLogics CEO responds to regulator's accountancy claims

AbbVie secures another Humira patent deal

Biologics delivery tech could accelerate wound healing by 80%, says Ilya Pharma

Five big pharma deals in Humira market could save UK £300m

Tech focus: Making waves with acoustic separation in cell processing

Products

Webinars

On-demand webinars

Marken: Global Life Science Supply Chain Solutions Exploring the value of home visits in clinical trials, the benefits gained by both the patient and the sponsor

Featured Suppliers

All suppliers

Baxter BioPharma Solutions

Bio-Rad Laboratories

Marken: Global Life Science Supply Chain Solutions

Merck KGaA, Darmstadt, Germany

Samsung BioLogics